A federal court in the Eastern District of California dismissed trademark infringement claims involving the ALIEN mark for nicotine products after the plaintiff failed, even on a second attempt, to adequately plead priority of use over the defendant’s ALIENLABS mark for cannabis products.
In a closely watched case, Judge Gilstrap denied a permanent injunction against Samsung despite a $445.5 million willful infringement verdict, finding that the non-practicing patent owner failed to show the balance of hardships favored relief — even though the court accepted its irreparable harm arg
A federal judge enters a $19.5 million default judgment against shadow library Anna’s Archive and orders global registries to disable the site’s remaining domains, marking the second massive judgment against the piracy operation in 2026.
A New Jersey federal court denied a preliminary injunction in a dispute between competing waterfront restaurants, holding that a restaurant logo known only in a regional market is not ‘famous’ enough for federal trademark dilution protection.
An Ohio federal court entered a $1 million default judgment against a convicted counterfeiter who placed unauthorized NIJ certification marks on body armor sold to law enforcement, ordering permanent injunction and destruction of infringing goods.
In a patent litigation over cancer diagnostics, a federal court adopted sanctions totaling nearly $3 million against Quinn Emanuel and five named attorneys, plus a $100,000 punitive sanction and mandatory ethics training, for deliberately misleading the court about an expert’s access to embarg
A federal court in Texas entered a $12.97 million judgment and permanent injunction against Talaria for willfully infringing Surron’s design patent covering its popular Light Bee electric off-road motorcycle.
An Oregon federal court partially dismissed adidas’s trademark infringement claims, holding that plaintiffs must identify which specific registered marks are infringed rather than pleading a ‘unitary branding device’ across multiple registrations.
A Delaware federal judge upheld two patents covering UCB’s Nayzilam seizure medication after a bench trial, finding that Cipla failed to prove the patents invalid as anticipated or obvious—preserving UCB’s market exclusivity just as the drug’s orphan drug protection expired.
A federal court in Pennsylvania granted summary judgment to a photographer whose copyrighted image was republished without permission on a commercial dog breeder’s blog, rejecting the defendant’s fair use defense on all four statutory factors.